FDA Is Revising Contact-Lens Guidelines To Protect Against Infections
This article was originally published in The Gray Sheet
Executive Summary
The agency’s ophthalmic device advisory panel is meeting in May to address FDA’s plans to revise guidance documents describing 510(k) submissions for contact lenses and lens care products. The changes would incorporate lessons learned since the infectious outbreaks linked to multipurpose contact lens solution in the past decade.
You may also be interested in...
FDA To Host Workshop On Contact Lens Product Microbiological Tests
Several professional societies and FDA are cosponsoring a public workshop, Sept. 12, for revamping microbiological test methods for contact lens products.
AMO’s Recalled MoisturePlus Lens Solution Had $106 Mil. In Sales Last Year
Advanced Medical Optics is recalling its Complete MoisturePlus contact lens solution after an investigation by the Centers for Disease Control and Prevention found a potential link between the product and a rare eye infection
B&L’s MoistureLoc Worldwide Recall: Firm Ties Formulation To Infection
With evidence pointing to the basic formulation of Bausch & Lomb's ReNu with MoistureLoc contact lens solution as a contributing factor in an outbreak of serious eye infections, the company bit the bullet May 15 and issued a permanent, worldwide recall of the lucrative product